Vivek Ranva
Our proprietary 2025 predictor index reveals AWL Agri may outperform by 18%—here’s why this FMCG-agri hybrid is drawing quiet FII interest After analyzing 50 top BSE midcap stocks, our team found that 22% returned over 18% in FY24—but what separated the winners wasn’t just momentum. It was policy-alignment, pricing power, and underappreciated growth. And this … Read more
Our analysis of 50 BSE-listed stocks reveals an average return of 22.4% in 2024, led by sectors like green energy and financial services. Using our proprietary “2025 Stock Predictor Index,” we decode the best stocks to invest in India and show you how to ride the next wave of wealth creation—before the crowd catches on. … Read more
🧠 Jio BlackRock Investment Advisers: What It Means for Your Financial Future 🚀 Introduction Jio BlackRock Investment Advisers is a groundbreaking joint venture between Jio Financial Services and BlackRock, one of the world’s largest asset managers. Approved by SEBI in June 2025, this new-age investment advisory aims to democratize wealth management in India with digital-first, … Read more
GNWL in Railway: Full Form, Confirmation Chances, and Why It Matters Booking train tickets in India often means encountering a maze of abbreviations. One of the most common is GNWL, which stands for General Waiting List. But what exactly does GNWL mean? How likely is your GNWL ticket to get confirmed? And how can you … Read more
Smartwatches dominate, while classic brands maintain niche demand amid festive sale surge By Vivek Ranva | July 12, 2025 | Updated 1:30 PM IST As Top 10 watch brands India Prime Day 2025 sale enters its peak phase, the watch category has seen significant traction, fueled by deep discounts, limited-time deals, and an expanding base … Read more
📈 Glenmark Pharma Share Price Hits Record High After $700 Million AbbVie Oncology Deal Mumbai, July 11, 2025 — The Glenmark Pharma share price surged to a new all-time high of ₹2,094 apiece on Friday, after the drugmaker announced a high-value global licensing deal with AbbVie, focused on its subsidiary’s novel oncology pipeline. Shares were … Read more
📊 Dividend, Rights Issue Stocks Today: Key Updates for Smart Investors Mumbai | July 11, 2025 — As Indian markets hover near record highs, income-focused investors are closely tracking today’s dividend-paying stocks and active rights issue offers. July 10–11 has emerged as a critical window for shareholders looking to lock in corporate payouts and assess … Read more